HAVA
NASDAQ · N/A
Harvard Ave Acquisition-Cl A
$10.00
+0.00 (+0.00%)
Open$10.00
Previous Close$10.00
Day High$10.00
Day Low$10.00
52W High$36.38
52W Low$14.67
Volume—
Avg Volume324.3K
Market Cap206.93M
P/E Ratio22.52
EPS$1.18
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 219.03M | 196.60M | 211.78M |
| Net Income | 8.69M | 7.47M | 7.70M |
| Profit Margin | 4.0% | 3.8% | 3.6% |
| EBITDA | 14.09M | 11.42M | 12.03M |
| Free Cash Flow | 7.43M | 6.90M | 7.76M |
| Rev Growth | +5.0% | -0.4% | +4.7% |
| Debt/Equity | 0.54 | 0.45 | 0.54 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $6.13 | +4.25% | — | 3.64B |
| PICS | Pics Nv | $15.73 | +4.73% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | -0.20% | — | 655.09M |
| CCCX | Churchill Capital Corp X-A | $11.66 | +8.57% | — | 606.90M |
| BEAG | Bold Eagle Acquisition Cor-A | $10.53 | +0.10% | 63.0 | 605.14M |
| CEPF | Cantor Equity Partners-Cl A | $10.46 | +0.48% | 364.8 | 597.79M |